A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies

NCT06820268 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Lymphoma
Acute Myeloid Leukemia
Myelodysplastic Syndrome

Interventions

DRUG: XS-04 tablet

Sponsor

NovaOnco Therapeutics Co., Ltd.